Cisen Pharmaceutical Co., Ltd. (SHA:603367)
China
· Delayed Price · Currency is CNY 17.21
+0.30 (1.77%)
Mar 10, 2026, 3:00 PM CST
Cisen Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,792 | 6,221 | 6,601 | 5,668 | 5,978 | 6,229 | Upgrade
|
| Market Cap Growth | 28.62% | -5.76% | 16.46% | -5.19% | -4.03% | -16.98% | Upgrade
|
| Enterprise Value | 4,531 | 3,782 | 4,082 | 3,364 | 3,917 | 3,923 | Upgrade
|
| Last Close Price | 17.21 | 13.40 | 13.65 | 11.48 | 11.87 | 12.11 | Upgrade
|
| PE Ratio | 15.93 | 12.22 | 12.66 | 16.20 | 17.89 | 14.20 | Upgrade
|
| Forward PE | - | 46.95 | 46.95 | 46.95 | 46.95 | 46.95 | Upgrade
|
| PS Ratio | 2.19 | 1.56 | 1.48 | 1.39 | 1.58 | 1.70 | Upgrade
|
| PB Ratio | 1.26 | 1.04 | 1.15 | 1.06 | 1.18 | 1.30 | Upgrade
|
| P/TBV Ratio | 1.31 | 1.08 | 1.20 | 1.11 | 1.23 | 1.36 | Upgrade
|
| P/FCF Ratio | 11.11 | 13.26 | 15.23 | 25.40 | 32.74 | 27.23 | Upgrade
|
| P/OCF Ratio | 9.58 | 10.90 | 14.63 | 21.94 | 25.59 | 14.45 | Upgrade
|
| EV/Sales Ratio | 1.27 | 0.95 | 0.92 | 0.83 | 1.03 | 1.07 | Upgrade
|
| EV/EBITDA Ratio | 7.49 | 5.53 | 5.22 | 6.47 | 9.07 | 7.58 | Upgrade
|
| EV/EBIT Ratio | 11.40 | 8.10 | 7.41 | 11.55 | 18.28 | 10.96 | Upgrade
|
| EV/FCF Ratio | 6.46 | 8.06 | 9.41 | 15.08 | 21.45 | 17.15 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 0.07 | 0.17 | 0.22 | 0.30 | 0.33 | 0.64 | Upgrade
|
| Debt / FCF Ratio | 0.06 | 0.25 | 0.39 | 0.71 | 0.79 | 1.44 | Upgrade
|
| Net Debt / Equity Ratio | -0.53 | -0.45 | -0.45 | -0.49 | -0.45 | -0.46 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.47 | -3.92 | -3.33 | -5.05 | -5.28 | -4.26 | Upgrade
|
| Net Debt / FCF Ratio | -4.71 | -5.71 | -6.01 | -11.76 | -12.49 | -9.65 | Upgrade
|
| Asset Turnover | 0.47 | 0.54 | 0.63 | 0.62 | 0.60 | 0.63 | Upgrade
|
| Inventory Turnover | 2.15 | 2.39 | 2.97 | 3.11 | 2.96 | 2.75 | Upgrade
|
| Quick Ratio | 3.32 | 2.72 | 3.02 | 3.17 | 2.86 | 2.56 | Upgrade
|
| Current Ratio | 4.05 | 3.33 | 3.63 | 3.70 | 3.40 | 3.08 | Upgrade
|
| Return on Equity (ROE) | 8.24% | 8.76% | 9.45% | 6.77% | 6.78% | 9.33% | Upgrade
|
| Return on Assets (ROA) | 3.29% | 3.92% | 4.87% | 2.76% | 2.14% | 3.82% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.91% | 12.90% | 16.48% | 10.17% | 7.92% | 13.17% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.30% | 7.70% | 9.20% | 5.30% | 4.20% | 7.30% | Upgrade
|
| Earnings Yield | 6.32% | 8.18% | 7.90% | 6.17% | 5.59% | 7.04% | Upgrade
|
| FCF Yield | 9.00% | 7.54% | 6.57% | 3.94% | 3.05% | 3.67% | Upgrade
|
| Dividend Yield | 2.22% | 3.28% | 3.19% | 2.92% | 2.53% | 2.11% | Upgrade
|
| Payout Ratio | 41.27% | 59.85% | 29.95% | 39.87% | 36.13% | 63.81% | Upgrade
|
| Buyback Yield / Dilution | -0.89% | -0.23% | 0.25% | -0.65% | 0.18% | -0.21% | Upgrade
|
| Total Shareholder Return | 1.33% | 3.05% | 3.45% | 2.27% | 2.71% | 1.90% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.